Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.40
+0.03 (0.36%)
Jan 29, 2026, 1:30 PM EST - Market open
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $215.17 million as of January 29, 2026. Its market cap has increased by 91.68% in one year.
Market Cap
215.17M
Enterprise Value
178.95M
1-Year Change
91.68%
Ranking
Category
Stock Price
$8.40
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $215.17M, an increase of 270.94%. That is a compound annual growth rate of 38.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 214.40M | 10.86% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonix Pharmaceuticals Holding | 226.64M |
| Orchestra BioMed Holdings | 221.91M |
| Voyager Therapeutics | 220.73M |
| Context Therapeutics | 220.51M |
| Inhibikase Therapeutics | 217.48M |
| SAB Biotherapeutics | 209.95M |
| Crescent Biopharma | 209.77M |
| Arcturus Therapeutics Holdings | 209.41M |